Safety and Efficacy of a Drug Delivery System in Glaucoma

NCT01016691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: High Dose Drug Device
DRUG: Low Dose Drug Device
DRUG: Placebo Device
DRUG: bimatoprost 0.03%

Sponsor

Vistakon Pharmaceuticals